Figure Legends
Figure 1. Patient 1 had over 50% reduction in size her LM after a year on alectinib. Sagittal T2 weighted MRI of the lumbar spine A) prior to alectinib and B) after one year on alectinib. Coronal gadolinium enhanced T1 weighted MRI of the lumbar spine C) prior to alectinib and D) after one year on alectinib.
Figure 2. Patient 2 with over 20% reduction in size of the labial component of her LM after 3 months on crizotinib. Coronal T2 weighted MRI of the pelvis A) at 13 years old prior to crizotinib therapy, and B) at 17 years old after 3 months on crizotinib therapy.